← Eichor
Condition: Prolactinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prolactinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Pasireotide in People With Prolactinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06295952How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07268183Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Phase 3 · 16 location(s) · University of Sao Paulo General Hospital · NCT07463235An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00001595Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Phase 4 · 1 location(s) · University Hospital, Basel, Switzerland · NCT07045935
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.